Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.
Yee, L J
Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. [electronic resource] - Hepatology (Baltimore, Md.) Mar 2001 - 708-12 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0270-9139
10.1053/jhep.2001.22347 doi
Alleles
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Gene Frequency
Genetic Variation
Haplotypes
Hepatitis C, Chronic--drug therapy
Heterozygote
Homozygote
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Interleukin-10--genetics
Polymorphism, Genetic
Prognosis
Recombinant Proteins
Ribavirin--therapeutic use
Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. [electronic resource] - Hepatology (Baltimore, Md.) Mar 2001 - 708-12 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0270-9139
10.1053/jhep.2001.22347 doi
Alleles
Antiviral Agents--therapeutic use
Drug Therapy, Combination
Gene Frequency
Genetic Variation
Haplotypes
Hepatitis C, Chronic--drug therapy
Heterozygote
Homozygote
Humans
Interferon alpha-2
Interferon-alpha--therapeutic use
Interleukin-10--genetics
Polymorphism, Genetic
Prognosis
Recombinant Proteins
Ribavirin--therapeutic use